We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
-4.96%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
10 Year Est. Return
AUM
$153M
AUM Growth
-$9.29M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 83.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.3B
$110M 71.84%
2,680,644
GDX icon
2
VanEck Gold Miners ETF
GDX
$27.4B
$25.1M 16.41%
738,500
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.4B
$10.7M 6.97%
602,272
YMAB
4
DELISTED
Y-mAbs Therapeutics
YMAB
$7.33M 4.79%
216,916

Similar funds

Memorial Sloan Kettering Cancer Center's Q2 2021 Portfolio in Review

As of Q2 2021, Memorial Sloan Kettering Cancer Center held 4 positions worth $153M, down 5.7% from $162M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 0%. Memorial Sloan Kettering Cancer Center opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $153M portfolio in Q2 2021.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q2 2021.
  • Memorial Sloan Kettering Cancer Center's portfolio value fell 5.7% quarter-over-quarter to $153M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q2 2021, filed 16 Aug 2021.